Overview

Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants

Status:
Completed

Trial end date:
2021-01-21

Target enrollment:

Participant gender:

Summary

In this study, researchers want to find whether the study drug BAY1817080 has an effect on the electrocardiogram (ECG). 40 healthy male or female participants with the age of 18 to 65 years will be enrolled into this study. The ECG of the participants will be monitored closely by the researchers to detect any change after intake of the study medication.

Phase:

Phase 1

Details

Lead Sponsor:

Bayer

Treatments:

Moxifloxacin